DAFNA Capital Management LLC - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 33 filers reported holding SPRING BK PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$110,000
-49.3%
6,507
+306.7%
0.07%
-56.1%
Q2 2017$217,000
-0.9%
1,600
-94.2%
0.16%
-19.3%
Q4 2016$219,00027,4120.19%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
BVF INC/IL 1,301,701$4,803,0000.52%
SECTORAL ASSET MANAGEMENT INC 276,656$1,021,0000.12%
PARSONS CAPITAL MANAGEMENT INC/RI 277,263$1,023,0000.11%
CAXTON CORP 23,821$88,0000.10%
TIEDEMANN ADVISORS, LLC 412,049$1,522,0000.08%
Private Capital Advisors, Inc. 52,335$193,0000.06%
Pegasus Asset Management, Inc. 18,750$69,0000.05%
Hikari Power Ltd 61,336$226,0000.02%
Lee Financial Co 18,750$69,0000.02%
Baker Brothers Advisors 613,144$2,263,0000.02%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders